In this Issue:
HEV infection: effects on innate immunity during pregnancy
Nucleos(t)ide analogue therapy modulates NK cell phenotype
Assess fibrotic burden + HBV DNA to predict risk of HCC
Data on DAAs for reducing vertical transmission of HCV
Changing incidence patterns of HCC in Taiwan
The early HBV-induced blockade of innate responses
A cell culture system for distinguishing HCV variants
Low oxygen tension impairs antiviral NK cell activity
A new adenovirus-based immunotherapy for HBV infection
Association between HDV RNA and Peg-IFN treatment outcomes
Please login below to download this issue (PDF)